Bilal Arif - 31 Dec 2022 Form 3 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Tech Ops Officer
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Bilal Arif
Issuer symbol
SRPT
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
3
Filing time
04 Jan 2023, 19:01:31 UTC
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SRPT Common Stock 22,917 31 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SRPT Stock Option (right to buy) 31 Dec 2022 Common Stock 8,300 $119.19 Direct F1
holding SRPT Stock Option (right to buy) 31 Dec 2022 Common Stock 4,800 $114.47 Direct F1
holding SRPT Stock Option (right to buy) 31 Dec 2022 Common Stock 4,200 $114.47 Direct F1
holding SRPT Stock Option (right to buy) 31 Dec 2022 Common Stock 4,950 $87.11 Direct F1
holding SRPT Stock Option (right to buy) 31 Dec 2022 Common Stock 5,000 $87.11 Direct F1
holding SRPT Stock Option (right to buy) 31 Dec 2022 Common Stock 8,400 $80.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter.